Published in J Immunol on March 01, 1988
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest (2006) 4.77
Two years later: journals are not yet enforcing the ARRIVE guidelines on reporting standards for pre-clinical animal studies. PLoS Biol (2014) 3.17
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03
IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med (1996) 2.69
IL-17 disrupts corneal barrier following desiccating stress. Mucosal Immunol (2009) 2.65
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med (1997) 2.51
Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation (2002) 2.49
Reversal of paralysis and reduced inflammation from peripheral administration of β-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Sci Transl Med (2012) 2.38
Spontaneous recovery of rats from experimental allergic encephalomyelitis is dependent on regulation of the immune system by endogenous adrenal corticosteroids. J Exp Med (1989) 2.32
An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med (1998) 2.26
Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med (1990) 2.25
Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci (2010) 2.08
A rush to judgment on Th17. J Exp Med (2008) 2.07
IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med (2005) 2.07
Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice. J Clin Invest (1998) 2.06
Antibodies to IFN-gamma prevent immunologically mediated intestinal damage in murine graft-versus-host reaction. Immunology (1989) 1.91
Mixed results with modulation of TH-17 cells in human autoimmune diseases. Nat Immunol (2009) 1.73
Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J Exp Med (1999) 1.70
Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. J Exp Med (1999) 1.69
IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J Neuroinflammation (2012) 1.54
Suppression of experimental allergic encephalomyelitis by intraventricular administration of interferon-gamma in Lewis rats. Clin Exp Immunol (1990) 1.53
Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1. J Immunol (2009) 1.46
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A (1996) 1.38
Nuanced roles of cytokines in three major human brain disorders. J Clin Invest (2008) 1.28
The neuroprotective role of inflammation in nervous system injuries. J Neurol (2004) 1.27
Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol (2009) 1.23
Cutting edge: IFN-gamma is a negative regulator of IL-23 in murine macrophages and experimental colitis. J Immunol (2010) 1.23
The cytokine milieu in the interplay of pathogenic Th1/Th17 cells and regulatory T cells in autoimmune disease. Cell Mol Immunol (2010) 1.21
Novel CD8+ Treg suppress EAE by TGF-beta- and IFN-gamma-dependent mechanisms. Eur J Immunol (2009) 1.18
More stories on Th17 cells. Cell Res (2009) 1.14
Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. J Neuroinflammation (2011) 1.11
The PD-1/PD-L pathway is up-regulated during IL-12-induced suppression of EAE mediated by IFN-gamma. J Neuroimmunol (2007) 1.07
IL-13 production by regulatory T cells protects against experimental autoimmune encephalomyelitis independently of autoantigen. J Immunol (2008) 1.04
Human gamma interferon strongly upregulates its own gene expression in peripheral blood lymphocytes. J Exp Med (1989) 1.02
New perspectives on effector mechanisms in uveitis. Semin Immunopathol (2008) 1.02
Subcutaneous insulin B:9-23/IFA immunisation induces Tregs that control late-stage prediabetes in NOD mice through IL-10 and IFNgamma. Diabetologia (2010) 1.02
Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin Exp Immunol (1993) 1.01
In vivo priming of T cells against cryptic determinants by dendritic cells exposed to interleukin 6 and native antigen. Proc Natl Acad Sci U S A (1998) 0.99
HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma. J Immunol (2008) 0.95
Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol (2005) 0.94
Interleukin-12 induces relapse in experimental allergic encephalomyelitis in the Lewis rat. Am J Pathol (1997) 0.93
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Mult Scler Int (2014) 0.93
Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity? Clin Exp Immunol (2009) 0.93
Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome. PLoS One (2011) 0.92
Immune response after experimental allergic encephalomyelitis in rats subjected to calorie restriction. J Neuroinflammation (2007) 0.91
ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis. J Clin Immunol (2009) 0.90
Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. J Immunol (2008) 0.90
Oligodendrocyte progenitors reversibly exit the cell cycle and give rise to astrocytes in response to interferon-γ. J Neurosci (2011) 0.89
The complement inhibitor FUT-175 suppresses T cell autoreactivity in experimental autoimmune encephalomyelitis. Am J Pathol (2009) 0.88
Islet antigen-specific Th17 cells can induce TNF-α-dependent autoimmune diabetes. J Immunol (2014) 0.88
IL-23 modulated myelin-specific T cells induce EAE via an IFNγ driven, IL-17 independent pathway. Brain Behav Immun (2010) 0.88
Retinal Astrocytes respond to IL-17 differently than Retinal Pigment Epithelial cells. J Leukoc Biol (2009) 0.87
The limited role of interferon-γ in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness. Arthritis Rheum (2012) 0.86
Induction of intestinal pro-inflammatory immune responses by lipoteichoic acid. J Inflamm (Lond) (2012) 0.85
The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol (2013) 0.85
Microbial epitopes act as altered peptide ligands to prevent experimental autoimmune encephalomyelitis. J Exp Med (1999) 0.85
T cell-, interleukin-12-, and gamma interferon-driven viral clearance in measles virus-infected brain tissue. J Virol (2011) 0.84
Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. J Immunol (2015) 0.83
IFN-γ-mediated induction of an apical IL-10 receptor on polarized intestinal epithelia. J Immunol (2013) 0.82
Cytokine networks in neuroinflammation. Nat Rev Immunol (2016) 0.81
Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis. Front Neurosci (2015) 0.81
The induction of renal autoantigen-specific T cells by a local Listeria monocytogenes infection. Immunology (1995) 0.81
Targeting innate receptors with MIS416 reshapes Th responses and suppresses CNS disease in a mouse model of multiple sclerosis. PLoS One (2014) 0.80
Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome. Arthritis Res Ther (2015) 0.80
Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol (2015) 0.80
Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes. J Neuroinflammation (2012) 0.79
Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β. J Neuroimmunol (2012) 0.78
Macrophages activated by Listeria monocytogenes induce organ-specific autoimmunity. Immunology (1997) 0.78
γδ T Cells and NK Cells - Distinct Pathogenic Roles as Innate-Like Immune Cells in CNS Autoimmunity. Front Immunol (2015) 0.77
Exacerbation of experimental autoimmune encephalomyelitis in mice deficient for DCIR, an inhibitory C-type lectin receptor. Exp Anim (2015) 0.77
Opposing Roles of Interferon-Gamma on Cells of the Central Nervous System in Autoimmune Neuroinflammation. Front Immunol (2015) 0.76
The role of Th17-associated cytokines in the pathogenesis of experimental autoimmune uveitis (EAU). Cytokine (2015) 0.76
Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis. Clin Exp Immunol (2015) 0.75
Interferon-gamma deficiency protects against aging-related goblet cell loss. Oncotarget (2016) 0.75
Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis. Curr Trends Immunol (2012) 0.75
Four decades of glucocorticosteroid immunosuppression. CMAJ (1993) 0.75
Anti-gamma interferon antibodies enhance the immunogenicity of recombinant adenovirus vectors. Clin Vaccine Immunol (2011) 0.75
IL-12Rβ2 has a protective role in relapsing-remitting experimental autoimmune encephalomyelitis. J Neuroimmunol (2015) 0.75
Influence of Interferon-γ Deficiency in Immune Tolerance Induced by Male Islet Transplantation. Immune Netw (2011) 0.75
Overcoming unresponsiveness in experimental autoimmune encephalomyelitis (EAE) resistant mouse strains by adoptive transfer and antigenic challenge. J Vis Exp (2012) 0.75
Beneficial effect of co-polymer 1 on cytokine production by CD4 T cells in multiple sclerosis. Immunology (2001) 0.75
Role of B:T cell ratio in suppression of clinical signs: a model for silent MS. Exp Mol Pathol (2008) 0.75
Low-dose interferon-α treatment improves survival and inflammatory responses in a mouse model of fulminant acute respiratory distress syndrome. Inflammation (2013) 0.75
The history of Belgian assisted reproduction technology cycle registration and control: a case study in reducing the incidence of multiple pregnancy. Hum Reprod (2013) 3.44
Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol (1997) 3.35
Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. Proc Natl Acad Sci U S A (1989) 3.03
The epidemiology of multiple sclerosis in Europe. Eur J Neurol (2006) 2.80
Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med (1990) 2.25
Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock. Eur J Clin Invest (1991) 2.17
Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol (1991) 2.08
Regulation by interferons of the local inflammatory response to bacterial lipopolysaccharide. J Immunol (1987) 1.91
Human interferon: mass production in a newly established cell line, MG-63. Antimicrob Agents Chemother (1977) 1.79
Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke (1999) 1.69
Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J Clin Invest (1999) 1.64
Polyneuropathy in lithium intoxication. Muscle Nerve (1990) 1.55
Beta-blockers: once or three times a day? Br Med J (1978) 1.54
Interferon treatment of NZB mice: accelerated progression of autoimmune disease. Infect Immun (1978) 1.53
Endogenous systemic IFN-gamma has a protective role against ocular autoimmunity in mice. J Immunol (1994) 1.53
Exogenous isolation of mobilizing plasmids from polluted soils and sludges. Appl Environ Microbiol (1994) 1.51
Interleukin 6 production in experimental cerebral malaria: modulation by anticytokine antibodies and possible role in hypergammaglobulinemia. J Exp Med (1990) 1.48
Severe cachexia in mice inoculated with interferon-gamma-producing tumor cells. Int J Cancer (1991) 1.47
Cooperation between bovine leukaemia virus transactivator protein and Ha-ras oncogene product in cellular transformation. EMBO J (1990) 1.44
Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction. Eur J Immunol (1987) 1.38
Anti-IL-12 antibody prevents the development and progression of collagen-induced arthritis in IFN-gamma receptor-deficient mice. Eur J Immunol (1998) 1.33
Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J Immunol (1999) 1.30
MRI of herpes simplex encephalitis. Neuroradiology (1992) 1.30
1,25-Dihydroxyvitamin D3 prevents insulitis in NOD mice. Diabetes (1992) 1.30
Immunomodulatory properties of interferon-gamma. An update. Ann N Y Acad Sci (1998) 1.29
Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res (1993) 1.25
Influence of interferon on virus particle formation in different oncornavirus carrier cell lines. Int J Cancer (1973) 1.24
Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release. Int J Cancer (1974) 1.24
Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol (1992) 1.22
Interleukin 6 production in the central nervous system during experimental autoimmune encephalomyelitis. Eur J Immunol (1990) 1.20
The induction of Trypanosoma cruzi trypomastigote to amastigote transformation by low pH. Parasitology (1995) 1.19
Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. J Immunol (2000) 1.17
Trapping of oncornavirus particles at the surface of interferon-treated cells. Virology (1976) 1.17
Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J Neuroimmunol (1996) 1.16
In vitro and in vivo oncogenic potential of bovine leukemia virus G4 protein. J Virol (1998) 1.14
Adult ceroid-lipofuscinosis (Kufs' disease) in two brothers. Retinal and visceral storage in one; diagnostic muscle biopsy in the other. Acta Neuropathol (1979) 1.14
A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution. J Neurol Neurosurg Psychiatry (1990) 1.13
Role of xanthine oxidase and reactive oxygen intermediates in LPS- and TNF-induced pulmonary edema. J Lab Clin Med (1994) 1.12
In vivo polyclonal B-lymphocyte activation elicited by murine viruses. J Virol (1990) 1.11
Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement. J Immunol (1994) 1.11
Globoid cell leukodystrophy: a family with both late-infantile and adult type. Neurology (1991) 1.10
A real-time quantitative reverse transcriptase polymerase chain reaction (RT-PCR) to detect breast carcinoma cells in peripheral blood. Ann Oncol (2001) 1.09
In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J Interferon Cytokine Res (2000) 1.09
Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia. Eur J Cancer (1991) 1.05
Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis. Eur J Immunol (2001) 1.05
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. J Neurol (2000) 1.04
Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun (1995) 1.04
Mutations in the bovine leukemia virus Tax protein can abrogate the long terminal repeat-directed transactivating activity without concomitant loss of transforming potential. Proc Natl Acad Sci U S A (1992) 1.04
Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3. J Neuroimmunol (1995) 1.03
B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J Immunol (2001) 1.03
Mammalian cell sialic acid enhances invasion by Trypanosoma cruzi. Infect Immun (1993) 1.03
HL-A determinants and familial multiple sclerosis: HL-A typing of 13 families with at least two affected members. Tissue Antigens (1978) 1.03
Prevalence of multiple sclerosis in Flanders, Belgium. Neuroepidemiology (1994) 1.03
In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression. Infect Immun (1996) 1.03
Induction of monocyte chemotactic proteins MCP-1 and MCP-2 in human fibroblasts and leukocytes by cytokines and cytokine inducers. Chemical synthesis of MCP-2 and development of a specific RIA. J Immunol (1994) 1.03
Selective up-regulation by interferon-gamma of surface molecules of the Ly-6 complex in resting T cells: the Ly-6A/E and TAP antigens are preferentially enhanced. Eur J Immunol (1987) 1.02
Inhibition of T-cell responsiveness during experimental infections with Trypanosoma brucei: active involvement of endogenous gamma interferon. Infect Immun (1993) 1.01
Efficacy of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)-cytosine and 9-(1,3-dihydroxy-2-propoxymethyl)-guanine in the treatment of intracerebral murine cytomegalovirus infections in immunocompetent and immunodeficient mice. Eur J Clin Microbiol Infect Dis (1993) 1.01
Interleukin-6 production in Mycobacterium bovis BCG-infected mice. Cell Immunol (1991) 1.01
Interleukin-6 (IL-6) production in mice infected with Trypanosoma cruzi: effect of its paradoxical increase by anti-IL-6 monoclonal antibody treatment on infection and acute-phase and humoral immune responses. Infect Immun (1994) 1.01
A papillomavirus related to HPV type 13 in oral focal epithelial hyperplasia in the pygmy chimpanzee. J Oral Pathol Med (1991) 1.00
Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes. Eur J Immunol (1993) 0.99
Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients. J Neurol Sci (1983) 0.99
NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency. J Immunol (1999) 0.99
The McGill Pain Questionnaire constructed for the Dutch language (MPQ-DV). Preliminary data concerning reliability and validity. Pain (1987) 0.99
Interferon induced in mouse spleen cells by Staphylococcus aureus. Cell Immunol (1982) 0.98
Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire. AIDS Res Hum Retroviruses (1994) 0.98
Characterization of a novel trans-sialidase of Trypanosoma brucei procyclic trypomastigotes and identification of procyclin as the main sialic acid acceptor. J Exp Med (1993) 0.98
Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels. Eur J Immunol (1993) 0.97
Efficient secretion of biologically active mouse tumor necrosis factor alpha by Streptomyces lividans. Gene (1994) 0.97
The cachexia associated with Trypanosoma cruzi acute infection in mice is attenuated by anti-TNF-alpha, but not by anti-IL-6 or anti-IFN-gamma antibodies. Parasite Immunol (1995) 0.96
Development of teratomas from displaced visceral yolk sac. Int J Cancer (1974) 0.96
In vitro cultivation of human tumor tissues. Oncology (1975) 0.96
Epidemic spastic paraparesis in Bandundu (Zaire). J Neurol Neurosurg Psychiatry (1986) 0.95
Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Antimicrob Agents Chemother (1979) 0.95
In vitro cultivation of human tumor tissues. II. Morphological and virological characterization of three cell lines. Oncology (1978) 0.95
Dysphagia in multiple sclerosis. Clin Neurol Neurosurg (2002) 0.93
Phosphorylation of bovine leukemia virus Tax protein is required for in vitro transformation but not for transactivation. Oncogene (1998) 0.93
Cross-border reproductive care in Belgium. Hum Reprod (2009) 0.93
Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy. Infect Immun (1980) 0.92
Pyrogenic and haematological effects of the interferon-inducing 22K factor (interleukin 1 beta) from human leukocytes. Clin Exp Immunol (1986) 0.92
Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. III. Survey of effects on A-, B- and C-type oncornaviruses. Int J Cancer (1975) 0.92
Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice. J Leukoc Biol (2000) 0.92
Respiratory muscle weakness and respiratory muscle training in severely disabled multiple sclerosis patients. Arch Phys Med Rehabil (2000) 0.91
Hypothermia in three patients with multiple sclerosis. Clin Neurol Neurosurg (1989) 0.91
IFN-gamma receptor-deficient mice are hypersensitive to the anti-CD3-induced cytokine release syndrome and thymocyte apoptosis. Protective role of endogenous nitric oxide. J Immunol (1995) 0.91
Inhibitory effects of 9-(2-phosphonylmethoxyethyl)adenine and 3'-azido-2',3'-dideoxythymidine on tumor development in mice inoculated intracerebrally with Moloney murine sarcoma virus. Int J Cancer (1990) 0.91
Interferon-gamma and interleukin-1 beta inhibit adipoconversion in cultured rodent preadipocytes. J Cell Physiol (1992) 0.90
Progressive ponto-bulbar palsy with deafness. A clinico-pathological study. Acta Neurol Belg (1976) 0.90
Clinical parameters and intrathecal IgG synthesis as prognostic features in multiple sclerosis. Part I. J Neurol (1983) 0.90
Stimulation of T cells and induction of interferon by toxic shock syndrome toxin 1. Rev Infect Dis (1989) 0.89
Interferon-gamma is cytotoxic for normal mouse fibroblasts: enhancement by tumor necrosis factor and interleukin 1. Lymphokine Res (1989) 0.89
Bladder cancer in patients with multiple sclerosis treated with cyclophosphamide. J Urol (1998) 0.89